Review



human il  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    R&D Systems human il
    Human Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pm41217002-574-5-11?v=R%26D+Systems
    Average 93 stars, based on 6 article reviews
    human il - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    human il  (R&D Systems)
    93
    R&D Systems human il
    Human Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pm41217002-574-5-11?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    human il - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    1035 il  (R&D Systems)
    93
    R&D Systems 1035 il
    1035 Il, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc10086458__gutjnl___2022___327166supp001-224-40-45?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    1035 il - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    15140122 recombinant human il 19 protein r d systems  (R&D Systems)
    93
    R&D Systems 15140122 recombinant human il 19 protein r d systems
    15140122 Recombinant Human Il 19 Protein R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc10086458__gutjnl___2022___327166supp001-224-32-37?v=R%26D+Systems
    Average 93 stars, based on 1 article reviews
    15140122 recombinant human il 19 protein r d systems - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    ifnα10 sino biological 10349 h08h 18 ifnα8 sino biological 10347 h08h 19 ifnα6 origene tp760329 20 il 2 peprotech  (OriGene)
    92
    OriGene ifnα10 sino biological 10349 h08h 18 ifnα8 sino biological 10347 h08h 19 ifnα6 origene tp760329 20 il 2 peprotech
    Ifnα10 Sino Biological 10349 H08h 18 Ifnα8 Sino Biological 10347 H08h 19 Ifnα6 Origene Tp760329 20 Il 2 Peprotech, supplied by OriGene, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc10972586__jciinsight___9___176556___s268-38-59-70?v=OriGene
    Average 92 stars, based on 1 article reviews
    ifnα10 sino biological 10349 h08h 18 ifnα8 sino biological 10347 h08h 19 ifnα6 origene tp760329 20 il 2 peprotech - by Bioz Stars, 2026-07
    92/100 stars
    		  Buy from Supplier
    recombinant interleukin 1α  (R&D Systems)
    91
    R&D Systems recombinant interleukin 1α
    Recombinant Interleukin 1α, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pm37683842-53-9-15?v=R%26D+Systems
    Average 91 stars, based on 1 article reviews
    recombinant interleukin 1α - by Bioz Stars, 2026-07
    91/100 stars
    		  Buy from Supplier
    il 19  (R&D Systems)
    91
    R&D Systems il 19
    Il 19, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pm36674793-196-34-57?v=R%26D+Systems
    Average 91 stars, based on 1 article reviews
    il 19 - by Bioz Stars, 2026-07
    91/100 stars
    		  Buy from Supplier
    human il-19 recombinant protein  (PeproTech)
    90
    PeproTech human il-19 recombinant protein
    ( A ) Quantification of EdU + A549 cells with IL20RB overexpression and/or treatment of CM from murine bone marrow–derived osteoclasts (OC) for 24 hours. Representative images are shown on the right. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( B ) Quantification of EdU + HBM1 cells with IL20RB knockdown and/or treatment with OC CM for 24 hours. ( C – E ) Organoid formation of A549 ( C ), HBM1 ( D ), and LLC ( E ) after treatment with OC CM. OC CM was mixed with organoid culture medium at a 1:3 ratio. ( F and G ) Organoid formation of A549 ( F ) and HBM1 ( G ) after treatment with OC CM and/or the IL-19–neutralizing antibody (10 μg/mL). ( H ) Organoid formation of LLC cells after treatment with <t>recombinant</t> IL-19 protein. ( I and J ) IL-19 secretion of osteoclasts after treatment with control F12K medium or CM from A549 ( I ) or HBM1 ( J ) with or without CSF2 knockdown. Scale bars: 100 μm. P values were obtained by 2-tailed unpaired t test. Data are represented as mean ± SD.
    Human Il 19 Recombinant Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc09566910-165-3-7?v=PeproTech
    Average 90 stars, based on 1 article reviews
    human il-19 recombinant protein - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human il 19  (R&D Systems Hematology)
    90
    R&D Systems Hematology human il 19
    ( A ) Quantification of EdU + A549 cells with IL20RB overexpression and/or treatment of CM from murine bone marrow–derived osteoclasts (OC) for 24 hours. Representative images are shown on the right. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( B ) Quantification of EdU + HBM1 cells with IL20RB knockdown and/or treatment with OC CM for 24 hours. ( C – E ) Organoid formation of A549 ( C ), HBM1 ( D ), and LLC ( E ) after treatment with OC CM. OC CM was mixed with organoid culture medium at a 1:3 ratio. ( F and G ) Organoid formation of A549 ( F ) and HBM1 ( G ) after treatment with OC CM and/or the IL-19–neutralizing antibody (10 μg/mL). ( H ) Organoid formation of LLC cells after treatment with <t>recombinant</t> IL-19 protein. ( I and J ) IL-19 secretion of osteoclasts after treatment with control F12K medium or CM from A549 ( I ) or HBM1 ( J ) with or without CSF2 knockdown. Scale bars: 100 μm. P values were obtained by 2-tailed unpaired t test. Data are represented as mean ± SD.
    Human Il 19, supplied by R&D Systems Hematology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc08801531-43-21-24?v=R%26D+Systems+Hematology
    Average 90 stars, based on 1 article reviews
    human il 19 - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human il 19  (R&D Systems)
    92
    R&D Systems human il 19
    ( A ) Quantification of EdU + A549 cells with IL20RB overexpression and/or treatment of CM from murine bone marrow–derived osteoclasts (OC) for 24 hours. Representative images are shown on the right. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( B ) Quantification of EdU + HBM1 cells with IL20RB knockdown and/or treatment with OC CM for 24 hours. ( C – E ) Organoid formation of A549 ( C ), HBM1 ( D ), and LLC ( E ) after treatment with OC CM. OC CM was mixed with organoid culture medium at a 1:3 ratio. ( F and G ) Organoid formation of A549 ( F ) and HBM1 ( G ) after treatment with OC CM and/or the IL-19–neutralizing antibody (10 μg/mL). ( H ) Organoid formation of LLC cells after treatment with <t>recombinant</t> IL-19 protein. ( I and J ) IL-19 secretion of osteoclasts after treatment with control F12K medium or CM from A549 ( I ) or HBM1 ( J ) with or without CSF2 knockdown. Scale bars: 100 μm. P values were obtained by 2-tailed unpaired t test. Data are represented as mean ± SD.
    Human Il 19, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il+19/pmc08311130-47-12-15?v=R%26D+Systems
    Average 92 stars, based on 1 article reviews
    human il 19 - by Bioz Stars, 2026-07
    92/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) Quantification of EdU + A549 cells with IL20RB overexpression and/or treatment of CM from murine bone marrow–derived osteoclasts (OC) for 24 hours. Representative images are shown on the right. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( B ) Quantification of EdU + HBM1 cells with IL20RB knockdown and/or treatment with OC CM for 24 hours. ( C – E ) Organoid formation of A549 ( C ), HBM1 ( D ), and LLC ( E ) after treatment with OC CM. OC CM was mixed with organoid culture medium at a 1:3 ratio. ( F and G ) Organoid formation of A549 ( F ) and HBM1 ( G ) after treatment with OC CM and/or the IL-19–neutralizing antibody (10 μg/mL). ( H ) Organoid formation of LLC cells after treatment with recombinant IL-19 protein. ( I and J ) IL-19 secretion of osteoclasts after treatment with control F12K medium or CM from A549 ( I ) or HBM1 ( J ) with or without CSF2 knockdown. Scale bars: 100 μm. P values were obtained by 2-tailed unpaired t test. Data are represented as mean ± SD.

    Journal: The Journal of Clinical Investigation

    Article Title: IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer

    doi: 10.1172/JCI157917

    Figure Lengend Snippet: ( A ) Quantification of EdU + A549 cells with IL20RB overexpression and/or treatment of CM from murine bone marrow–derived osteoclasts (OC) for 24 hours. Representative images are shown on the right. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( B ) Quantification of EdU + HBM1 cells with IL20RB knockdown and/or treatment with OC CM for 24 hours. ( C – E ) Organoid formation of A549 ( C ), HBM1 ( D ), and LLC ( E ) after treatment with OC CM. OC CM was mixed with organoid culture medium at a 1:3 ratio. ( F and G ) Organoid formation of A549 ( F ) and HBM1 ( G ) after treatment with OC CM and/or the IL-19–neutralizing antibody (10 μg/mL). ( H ) Organoid formation of LLC cells after treatment with recombinant IL-19 protein. ( I and J ) IL-19 secretion of osteoclasts after treatment with control F12K medium or CM from A549 ( I ) or HBM1 ( J ) with or without CSF2 knockdown. Scale bars: 100 μm. P values were obtained by 2-tailed unpaired t test. Data are represented as mean ± SD.

    Article Snippet: The human IL-19 recombinant protein was from Peprotech (catalog 200-19-10).

    Techniques: Over Expression, Derivative Assay, Knockdown, Recombinant, Control

    ( A and B ) Phosphorylation of JAK1 and STAT3 in A549 with or without IL20RB overexpression ( A ) and HBM1 with or without IL20RB knockdown ( B ) after treatment with OC CM for 24 hours. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( C ) STAT3-responsive reporter activity in A549 with or without IL20RB overexpression after treatment with OC CM for 24 hours. ( D and E ) Phosphorylation of JAK1 and STAT3 ( D ) and STAT3-responsive reporter activity ( E ) in A549 with or without IL20RB overexpression after treatment with OC CM and/or IL-19–neutralizing antibody (10 μg/mL) for 24 hours. ( F and G ) Phosphorylation of JAK1 and STAT3 in A549 with or without IL20RB overexpression ( F ) and HBM1 with or without IL20RB knockdown ( G ) after treatment with IL-19 recombinant protein (25 ng/mL) for 15 minutes. ( H ) STAT3-responsive reporter activity in A549 with or without IL20RB overexpression after treatment with IL-19 recombinant protein (25 ng/mL) for 15 minutes. ( I ) Correlation between IL-20RB expression and STAT3 phosphorylation in the SHTCH lung cancer cohort ( n = 19 patients). Representative immunostaining images are shown on the right. Scale bar: 100 μm. P values were obtained by 2-tailed unpaired t test ( C , E , and H ) and Pearson’s correlation analysis ( I ). Data are represented as mean ± SD.

    Journal: The Journal of Clinical Investigation

    Article Title: IL-20RB mediates tumoral response to osteoclastic niches and promotes bone metastasis of lung cancer

    doi: 10.1172/JCI157917

    Figure Lengend Snippet: ( A and B ) Phosphorylation of JAK1 and STAT3 in A549 with or without IL20RB overexpression ( A ) and HBM1 with or without IL20RB knockdown ( B ) after treatment with OC CM for 24 hours. OC CM was mixed with A549 culture medium at a 1:3 ratio. ( C ) STAT3-responsive reporter activity in A549 with or without IL20RB overexpression after treatment with OC CM for 24 hours. ( D and E ) Phosphorylation of JAK1 and STAT3 ( D ) and STAT3-responsive reporter activity ( E ) in A549 with or without IL20RB overexpression after treatment with OC CM and/or IL-19–neutralizing antibody (10 μg/mL) for 24 hours. ( F and G ) Phosphorylation of JAK1 and STAT3 in A549 with or without IL20RB overexpression ( F ) and HBM1 with or without IL20RB knockdown ( G ) after treatment with IL-19 recombinant protein (25 ng/mL) for 15 minutes. ( H ) STAT3-responsive reporter activity in A549 with or without IL20RB overexpression after treatment with IL-19 recombinant protein (25 ng/mL) for 15 minutes. ( I ) Correlation between IL-20RB expression and STAT3 phosphorylation in the SHTCH lung cancer cohort ( n = 19 patients). Representative immunostaining images are shown on the right. Scale bar: 100 μm. P values were obtained by 2-tailed unpaired t test ( C , E , and H ) and Pearson’s correlation analysis ( I ). Data are represented as mean ± SD.

    Article Snippet: The human IL-19 recombinant protein was from Peprotech (catalog 200-19-10).

    Techniques: Phospho-proteomics, Over Expression, Knockdown, Activity Assay, Recombinant, Expressing, Immunostaining